Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
antibodies
Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Vaccines Won’t Protect Millions of Patients With Crippled Immune Systems
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Una vacuna de bajo costo contra la COVID-19 está en marcha
Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la pandemia.
Una vacuna de bajo costo contra la COVID-19 está en marcha
Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la pandemia.
Researchers Are Hatching a Low-Cost Covid-19 Vaccine
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
Researchers Are Hatching a Low-Cost Covid-19 Vaccine
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
Researchers Are Hatching a Low-Cost Coronavirus Vaccine
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
Gilead Expands its Collaboration with AbCellera to Develop Antibodies Against Multiple Indications
Shots: AbCellera to receive upfront, milestone, and royalties based on the development and commercialization of Abs, emerge under the collaboration The expanded collaboration will utilize AbCellera’s technology stack, which includes Trianni Mouse and OrthoMab protein engineering platform AbCellera will generate panels of Abs against up… Read More »Gilead Expands its Collaboration with AbCellera to Develop Antibodies Against Multiple Indications
ViewPoints Interview: Lumen’s Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment for COVID-19
In an interview with PharmaShots, Brian Finrow, Co-Founder and CEO of Lumen Bioscience shared his views on the critical need for a scalable and cheaper method to engineer antibodies as a potential treatment for Covid-19. He also shed light on why it is time for… Read More »ViewPoints Interview: Lumen’s Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment for COVID-19
ViewPoints Interview: Adagio Therapeutics’ Tillman Gerngross Shares Insight on the Development of Antibodies to Prevent COVID-19
In an interview with PharmaShots, Tillman Gerngross, Ph.D., Co-Founder, and CEO of Adagio Therapeutics shed light on the pre-clinical data of ADG2 and how it works on SARS-CoV-2. Shots: ADG2 showed broad and potent neutralizing activity against SARS-CoV and two SARS-related coronaviruses currently known to… Read More »ViewPoints Interview: Adagio Therapeutics’ Tillman Gerngross Shares Insight on the Development of Antibodies to Prevent COVID-19
U.S. Buys 100,000 Doses of an Eli Lilly Antibody Treatment
The government will pay $210 million for the doses, which Eli Lilly will ship by the end of March.
U.S. Buys 100,000 Doses of an Eli Lilly Antibody Treatment
The government will pay $210 million for the doses, which Eli Lilly will ship by the end of March.
U.S. Buys 100,000 Doses of an Eli Lilly Antibody Treatment
The government will pay $210 million for the doses, which Eli Lilly will ship by the end of March.
F.D.A. Authorizes Another Antibody Treatment
Researchers hope Eli Lilly’s new combination therapy will be better able to fight virus variants than a similar treatment already in use.
F.D.A. Authorizes Another Antibody Treatment
Researchers hope Eli Lilly’s new combination therapy will be better able to fight virus variants than a similar treatment already in use.
F.D.A. Authorizes Another Antibody Treatment
Researchers hope Eli Lilly’s new combination therapy may be better able to fight virus variants than a similar treatment already in use.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claims
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
What to Know of Covid-19 Antibody Drugs: Cost, Availability and More
Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.
Why Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
Why Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
What You Need to Know About the Covid Drugs That Could Help Many
Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.
What to Know of Covid-19 Antibody Drugs: Cost, Availability and More
Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.
Covid Meds Are Scarce, but Not for Trump Cronies
Rudy Giuliani got monoclonal antibodies. You probably can’t.
Covid Meds Are Scarce, but Not for Trump Cronies
Rudy Giuliani got monoclonal antibodies. You probably can’t.
Trump and Friends Got Coronavirus Care Many Others Couldn’t
Rudolph W. Giuliani became the latest in President Trump’s inner circle to boast about the treatment he received for Covid-19, as hospitals across the country ration care.
F.D.A. Grants Emergency Authorization of Antibody Treatment Given to Trump
The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease.
Model-based Strategy to Guide the Choice of Clinical Doses for ADC
Chemotherapy has been a powerful method for fighting cancer for decades. One of the most effective therapies available, it is also known for weakening the patient and causing harsh side effects like pain, nausea, and hair loss. This is because in its zeal to attack… Read More »Model-based Strategy to Guide the Choice of Clinical Doses for ADC
Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US
Shots: Qiagen reports the launch of the Access Anti-SARS-CoV-2 Total test that runs on a portable device and provides accurate results on Total Ig Abs (IgA, IgM, IgG) in 10mins. The device can process up to 8 samples simultaneously or up to 32 tests/hour The… Read More »Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US
StartUPDATES: New developments from healthcare startups
News from innovative healthcare startups from Specifica, Aerovate Therapeutics and more.